Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€29.60

€29.60

-1.330%
-0.4
-1.330%
-

-

 
06.02.26 / Stuttgart Stock Exchange WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Your prediction

Vericel Corp. Stock

A loss of -1.330% shows a downward development for Vericel Corp..
So far the community has only identified positive things for Vericel Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Vericel Corp. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Vericel Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Vericel Corp. -1.330% - -7.500% -45.185% -6.329% 9.145% -30.954%
Twist Bioscience Corp 3.460% -0.721% 19.572% -7.874% 48.294% 84.746% -70.288%
SCYNEXIS Inc. 3.660% 4.221% 10.690% -42.370% 21.822% -59.850% -91.265%
Corcept Therapeutics Inc. 3.930% -2.578% 7.719% -52.176% -50.819% 50.000% 44.957%

Comments

Sell Vericel Corp.
Show more

News

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

On Tuesday, Baltimore-based Brown Capital Management reported selling 861,020 shares of Vericel Corporation for an estimated $30.9 million based on the average share price in the third quarter.